Duffau P - Search Results

1

[Building partnerships from the training of advanced practice nurses].

Berger V, Chevret E, Duffau P. Berger V, et al. Among authors: duffau p. Soins. 2022 Jun;67(866):14-16. doi: 10.1016/j.soin.2022.05.022. Epub 2022 May 26. Soins. 2022. PMID: 36127013 Free article. French.

2

Mitapivat versus Placebo for Pyruvate Kinase Deficiency.

Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators. Al-Samkari H, et al. N Engl J Med. 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. N Engl J Med. 2022. PMID: 35417638 Clinical Trial.

3

Cocaïne et lésions destructrices centro-faciales : à propos d'un cas.

Blaison F, Faganello D, Goigoux C, Mercié P, Baulier G, Contin-Bordes C, Duffau P. Blaison F, et al. Among authors: duffau p. Rev Med Interne. 2020 Sep;41(9):622-627. doi: 10.1016/j.revmed.2020.04.010. Epub 2020 Jul 11. Rev Med Interne. 2020. PMID: 32660858 French.

4

Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016 : Care for the asplenic patient in general practice.

Quéffélec C, Billet L, Duffau P, Lazaro E, Machelart I, Greib C, Viallard JF, Pellegrin JL, Rivière E. Quéffélec C, et al. Among authors: duffau p. BMC Fam Pract. 2020 Aug 12;21(1):163. doi: 10.1186/s12875-020-01237-3. BMC Fam Pract. 2020. PMID: 32787857 Free PMC article.

5

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study.

Lahouati M, Cazanave C, Labadie A, Gohier P, Guirlé L, Desclaux A, Gigan M, Malvy D, Pedeboscq S, Xuereb F, Duvignaud A; Bordeaux COVID-19 Treatment Group. Lahouati M, et al. Sci Rep. 2023 Sep 16;13(1):15357. doi: 10.1038/s41598-023-42727-5. Sci Rep. 2023. PMID: 37717101 Free PMC article.

6

[When to suspect immunologic deficiency?].

Duffau P, Pellegrin JL. Duffau P, et al. Rev Prat. 2007 Oct 15;57(15):1665-70. Rev Prat. 2007. PMID: 18080424 French.

7

Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort.

Tang MH, Mathis S, Duffau P, Cazenave P, Solé G, Duval F, Soulages A, Le Masson G. Tang MH, et al. Among authors: duffau p. J Neurol. 2020 Feb;267(2):561-571. doi: 10.1007/s00415-019-09618-0. Epub 2019 Nov 8. J Neurol. 2020. PMID: 31705291

8

Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare.

Ribeiro E, Cressend T, Duffau P, Grenouillet-Delacre M, Rouanet-Larivière M, Vital A, Longy-Boursier M, Mercié P. Ribeiro E, et al. Among authors: duffau p. Case Rep Med. 2009;2009:738293. doi: 10.1155/2009/738293. Epub 2010 Mar 14. Case Rep Med. 2009. PMID: 20300599 Free PMC article.

9

Tocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineage.

Richez C, Barnetche T, Khoryati L, Duffau P, Kostine M, Contin-Bordes C, Blanco P, Schaeverbeke T. Richez C, et al. Among authors: duffau p. J Rheumatol. 2012 Jun;39(6):1192-7. doi: 10.3899/jrheum.111439. Epub 2012 Apr 1. J Rheumatol. 2012. PMID: 22467922 Clinical Trial.

10

[An exophtalmos].

Raffray L, Bertolotti A, Duffau P, Longueville E, Mercié P, Longy-Boursier M. Raffray L, et al. Among authors: duffau p. Presse Med. 2013 Dec;42(12):1674-7. doi: 10.1016/j.lpm.2013.03.014. Epub 2013 Oct 18. Presse Med. 2013. PMID: 24144886 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page